Literature DB >> 6245031

Liposomes as vehicles for cellular incorporation of biologically active macromolecules.

D Paphadjopoulos, T Wilson, R Taber.   

Abstract

Lipid vesicles (liposomes) have recently been shown to be a useful vehicle for the delivery of a variety of compounds to cultured cells. Using large unilamellar vesicles composed of phosphatidylserine [LUV(PS)] we were able to encapsulate poliovirus and purified poliovirus ribonucleic acid (RNA) and show that it can be delivered efficiently to cells in an infectious form. LUV-entrapped poliovirus RNA produced infectious titers 100-fold higher than comparable RNA preparations delivered to cells by other techniques. We have made a quantitative analysis of the uptake and infectivity of the vesicle-encapsulated RNA by using various ratios of RNA copies per vesicle and by determining the percentage uptake of labelled lipid and RNA by HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245031     DOI: 10.1007/bf02618199

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  22 in total

1.  The introduction of poliovirus RNA into cells via lipid vesicles (liposomes).

Authors:  T Wilson; D Papahadjopoulos; R Taber
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

2.  The encapsulation of picornaviruses by lipid vesicles: physical and biological properties.

Authors:  R Taber; T Wilson; D Papahadjopoulos
Journal:  Ann N Y Acad Sci       Date:  1978       Impact factor: 5.691

3.  Cellular uptake and protection against virus infection by polyinosinic-polycytidylic acid entrapped within phospholipid vesicles.

Authors:  E Mayhew; D Papahadjopoulos; J A O'Malley; W A Carter; W J Vail
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

4.  Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells.

Authors:  D Papahadjopoulos; G Poste; W J Vail; J L Biedler
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

5.  The carrier potential of liposomes in biology and medicine (first of two parts).

Authors:  G Gregoriadis
Journal:  N Engl J Med       Date:  1976-09-23       Impact factor: 91.245

6.  Enzyme-containing liposomes alleviate a model for storage disease.

Authors:  G Gregoriadis; R A Buckland
Journal:  Nature       Date:  1973-07-20       Impact factor: 49.962

7.  Evidence for translation of rabbit globin mRNA after liposome-mediated insertion into a human cell line.

Authors:  M J Ostro; D Giacomoni; D Lavelle; W Paxton; S Dray
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

8.  Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.

Authors:  Y M Rustum; C Dave; E Mayhew; D Papahadjopoulos
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

9.  Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles.

Authors:  E Mayhew; D Papahadjopoulos; Y M Rustum; C Dave
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

10.  A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells.

Authors:  G Weissmann; D Bloomgarden; R Kaplan; C Cohen; S Hoffstein; T Collins; A Gotlieb; D Nagle
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

View more
  4 in total

1.  Suppression of liver uptake of liposomes by dextran sulfate 500.

Authors:  K R Patel; M P Li; J D Baldeschwieler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

Review 2.  Lipid Nanoparticles for Ocular Gene Delivery.

Authors:  Yuhong Wang; Ammaji Rajala; Raju V S Rajala
Journal:  J Funct Biomater       Date:  2015-06-08

3.  Encapsulation of "core" eIF3, regulatory components of eIF3 and mRNA into liposomes, and their subsequent uptake into myogenic cells in culture.

Authors:  J O'Loughlin; L Lehr; A Havaranis; S M Heywood
Journal:  J Cell Biol       Date:  1981-07       Impact factor: 10.539

Review 4.  Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.

Authors:  Yong Gao; Chanuka Wijewardhana; Jamie F S Mann
Journal:  Front Immunol       Date:  2018-02-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.